Navigation Links
UC Berkeley virologist named Keck Distinguished Young Scholar
Date:7/30/2008

Britt Glaunsinger, a University of California, Berkeley, virologist and an assistant professor in the Department of Plant and Microbial Biology, has won a W. M. Keck Foundation grant, an award given to innovative young scientists in the area of biomedical research.

The grant, which totals up to $1 million over five years, will go to UC Berkeley to support Glaunsinger's work using the herpesvirus as a tool to study the inner workings of human cells.

The foundation granted five Distinguished Young Scholars in Medical Research awards this year. Officials at the W. M. Keck Foundation, which supports pioneering medical research, announced the winners on July 28.

"Over the past decade, Keck Young Scholars have consistently produced high-impact research and have advanced to become some of the most prominent scientists in their respective fields," said Robert A. Day, chairman and chief executive officer of the W. M. Keck Foundation, in a prepared statement. "We are proud to have helped jump-start the careers of some of our nation's research leaders and are very pleased to support a new group of young scholars who we believe have the same potential."

Glaunsinger said she is ecstatic to be a recipient. "The great thing about the award is that they are funding ideas that might be too risky for other grant agencies. It allows you to pursue unconventional avenues and get at questions we wouldn't normally be able to ask without this funding," she said. "This pretty much made my year."

Glaunsinger will use the grant money for innovative experiments using the herpesvirus to probe how our cells regulate their RNA. The virus uses a mysterious trick to evade the immune response: It destroys all the RNA inside every cell it infects. Glaunsinger's research group has identified the key viral protein involved in the widespread destruction, but no one yet understands how it works.

Glaunsinger thinks the virus is co-opting some of the cell's normal machinery to regulate RNA stability. Some RNA molecules are long-lived, and some are turned over very quickly, depending on their function. The cell has finely-tuned mechanisms to maintain or destroy RNA molecules, Glaunsinger said, but these mechanisms are largely not understood. By learning which pieces of the machinery the virus adopts for its own uses, Glaunsinger hopes to uncover the workings of the cellular machinery itself.

Glaunsinger received her Ph.D. in molecular virology and microbiology from Baylor College of Medicine in 2001. She joined the UC Berkeley faculty in 2006. In 2007, she received the Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease Award, another prestigious award for young scientists.

The four other recipients of the Keck award are Dr. Carl Novina, assistant professor in cancer immunology and AIDS in the Dana-Farber Cancer Institute in Boston, Mass.; Coleen Murphy, assistant professor of molecular biology at Princeton University; Joanna Wysocka, assistant professor of chemical and systems biology and developmental biology at Stanford University; and Peter Reddien, member of the Whitehead Institute in Cambridge, Mass.

The Keck Distinguished Young Scholars in Medical Research program was established in 1998. Since then, it has awarded 49 grants to research universities and institutions. UC Berkeley last received one of these grants in 2005, to support the work of Lu Chen, assistant professor of neurobiology. "Now in its tenth year, our Young Scholars program helps to promote the early career development of some of the country's most promising biomedical scientists," said Day.


'/>"/>

Contact: Rachel Tompa
rmtompa@berkeley.edu
510-643-1331
University of California - Berkeley
Source:Eurekalert

Related biology news :

1. Berkeley researchers identify photosynthetic dimmer switch
2. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
3. UD named a regional research participant in National Children’s Study
4. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
5. NJIT start-up company NeuroTrax named best in show
6. Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
7. Journal of Womens Health named official journal of American Medical Womens Association
8. Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator
9. 4 Stanford faculty named Howard Hughes Medical Institute Investigators
10. Erich Jarvis named Howard Hughes Investigator
11. 2 University of Illinois researchers named HHMI investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... ... Well, look no further than LaJollaCooks4u, San Diego’s premiere hands-on cooking experience. Offering ... need to give mom an experience she won’t forget. , Guests that visit ...
(Date:5/4/2016)... ... ... Proove Biosciences, Inc. , the commercial and research leader in personalized pain ... partnership is designed to advance research in pain genetics in an effort to bring ... new agreement, researchers at Proove Biosciences are able to collaborate with Luda Diatechnko, MD, ...
(Date:5/4/2016)... , May 4, 2016  Bayer today ... oncology compound Stivarga ® (regorafenib) tablets for ... (HCC) has met its primary endpoint of a ... called RESORCE, evaluated the efficacy and safety of ... progressed after treatment with sorafenib. The safety and ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, 2016 , ... ... neurofibromatosis (NF), a genetic disorder that causes tumors to grow on nerves throughout the ... treatment or cure. , Through numerous community events held during the month of May, ...
Breaking Biology Technology: